4//SEC Filing
Seehra Jasbir 4
Accession 0001209191-23-023991
CIK 0001664710other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 4:05 PM ET
Size
6.8 KB
Accession
0001209191-23-023991
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-04-08$0.48/sh+4,000$1,920→ 252,856 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-04-08−4,000→ 45,087 totalExercise: $0.48Exp: 2029-06-18→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]Fully vested and exercisable.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001732369
Filing Metadata
- Form type
- 4
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 4:05 PM ET
- Size
- 6.8 KB